English (Singapore)
Melayu
中文(新加坡)

Forms

CLEAR

Disease Information
- English (Singapore) Melayu Chinese Singapore
For Healthcare Professionals Only
仅针对医疗保健专业人员

Legal

Report an Adverse Event

About

Privacy Policy
Terms of Use

Reporting Adverse Events

Repatha^® (evolocumab) is subject to additional monitoring. Adverse events should be reported. Reporting forms and information can be found:

www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Amgen Limited on:

+44 (0) 1223 436 441

If you think there may be a defect or quality issue with the Amgen product you have received, please provide us with the details via phone call:

+44 (0) 1223 436 441

×

X